Understanding the epidemiology and progression of systemic lupus erythematosus - Wikidata - awgldk - TriplyDB

Understanding the epidemiology and progression of systemic lupus erythematosus

Understanding the epidemiology and progression of systemic lupus erythematosus

http://www.wikidata.org/entity/Q33621131

about

Survival in systemic lupus erythematosus, 1995-2010. A prospective study in a Danish community Lupus Nephritis: A Different Disease in European Patients?Systemic lupus erythematosus: strategies to improve pregnancy outcomes Dendritic Cells in Systemic Lupus Erythematosus: From Pathogenic Players to Therapeutic Tools Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway Inflammatory etiopathogenesis of systemic lupus erythematosus: an update Non-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosus Cellular targeting in autoimmunity Biomarkers for CNS involvement in pediatric lupus Emerging therapies for systemic lupus erythematosus--focus on targeting interferon-alpha The effect of mycophenolate mofetil on disease development in the gld.apoE (-/-) mouse model of accelerated atherosclerosis and systemic lupus erythematosus Serum thiols as a biomarker of disease activity in lupus nephritis Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study Belimumab: a technological advance for systemic lupus erythematosus patients? Report of a systematic review and meta-analysis Impact of sex disparities on the clinical manifestations in patients with systemic lupus erythematosus: A systematic review and meta-analysis.CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases.Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents.Solving the genetic puzzle of systemic lupus erythematosus.Sex differences in patients with systemic lupus erythematosus from Northwest Spain.Comparison of ethnicity, gender, age of onset and outcome in South Africans with systemic lupus erythematosus.Surface complement C3 fragments and cellular binding of microparticles in patients with SLE Macrophage migration inhibitory factor: association of -794 CATT5-8 and -173 G>C polymorphisms with TNF-α in systemic lupus erythematosus.Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease.ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry.Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus.Superwoman schema: African American women's views on stress, strength, and health.Macrophage migration inhibitory factor (MIF) promoter polymorphisms (-794 CATT5-8 and -173 G>C): association with MIF and TNFα in psoriatic arthritis.Association of systemic lupus erythematosus with uranium exposure in a community living near a uranium-processing plant: a nested case-control study Incidence and prevalence of lupus in Buenos Aires, Argentina: a 11-year health management organisation-based study Reduced response to Epstein-Barr virus antigens by T-cells in systemic lupus erythematosus patients.Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.Lupus: an overview of the disease and management options.Renal involvement in autoimmune connective tissue diseases.Systemic lupus erythematosus and vitamin D deficiency are associated with shorter telomere length among African Americans: a case-control study.Interobserver agreement on histopathological lesions in class III or IV lupus nephritis Psychosocial dimensions of SLE: implications for the health care team Autoimmunity: an underlying factor in the pathogenesis of hypertension.Increased risk of chronic obstructive pulmonary disease in patients with systemic lupus erythematosus: a population-based cohort study.A systematic review of prevalence, disease characteristics and management of systemic lupus erythematosus in Australia: identifying areas of unmet need.The dysregulation of cytokine networks in systemic lupus erythematosus.

P2860

Q22299249-32016980-7A33-4A66-BDB2-3C018E1889CC Q26740483-123212A6-DE59-4772-908E-01CE2AB0C338 Q26741149-DAC5A0DB-C9E6-4E02-B122-59CA41A3B962 Q26749296-256A6033-7D91-4B6B-8EE1-7E3BD0149665 Q26768534-3FB2561A-5B59-44EB-B402-CA723250C3B1 Q26796413-D8C60787-2C05-42AE-88BF-38E26F739322 Q26796871-5A2D9794-A084-4B8C-97DD-A3B636788D2D Q26824580-21676A4D-08E2-4173-B19C-A8A453C181B3 Q28082493-44FD8D3F-366C-47F7-9AC6-EFFA5DF7B83A Q28265144-E8E98570-7CF4-46E0-9E1A-A9524B251187 Q28486062-9CBA3D0F-6296-43A2-9C35-F6F93533A0ED Q28544828-4EEF3EEF-2729-43FD-B708-98595F893022 Q28660706-3E761B72-5300-436A-ACC4-EA7007B0E7F4 Q28676968-BA6DD1C6-8BEA-4F8C-BC40-8BF8020AD744 Q30248879-707522E5-68F8-4D9F-B699-E46E99277C05 Q30388433-623B9228-B565-47C4-B99B-80FAA5316215 Q30451483-D6DD2E7B-558F-43EB-8A73-8C12078936BA Q33359121-8484B84D-A1FF-477A-B2FC-DDF60378D60F Q33408763-A00E4089-F780-4494-88C6-1BFD6454344D Q33436712-10A9D626-BB4E-4DB9-81FA-CE114FF5E970 Q33552712-60CF1F2C-56BE-40BA-BCCC-90AEB44A2B11 Q33598493-BF036E25-E30F-4BBB-80BF-0F9969EB48F3 Q33631871-1AA07F69-8742-4A1B-9512-12D3B3D2AA1E Q33939594-A0D86119-E02D-464E-A48B-D81D5D52FD17 Q34021798-156E47D2-9208-44AF-95EB-6A86EE752F1F Q34098653-334835A5-C40E-4BE2-B99E-F5AF1EDEA61D Q34414970-79788A3C-0F9C-4BBC-A4C9-E7D454A0C060 Q34415786-71FB9778-B658-46B6-8F95-F3773BF9A0A2 Q34424638-4D44A23E-75CA-4567-8D99-6D4D2CE5C6A1 Q34478829-B7A83598-3C4E-496D-B475-DA68EE014D38 Q34629180-9153BBF1-65E6-47AE-ABFC-63AE27937A08 Q34638296-B6851500-E3D4-49CC-9E0D-9FDE88F05216 Q34654954-036F3F42-D40F-467E-ADC7-B65864552F07 Q34735179-96AEEC3D-E7F5-4BA9-8451-FCB6DFEEE124 Q34828598-4A43C37A-5798-4AA6-AD65-F6F9AC2B54F2 Q34979305-E062202F-B54E-4D6E-B0CA-56B907BBB00B Q35116086-70D3AE86-CC00-43CD-ACE5-14716BF8F726 Q35119021-74F1983F-D333-49B4-803E-564270940D81 Q35234558-7F617AFB-E842-424B-B5BC-B2C2CC8EBE74 Q35294513-4794D194-E94C-40E9-88D5-D4BEE183EC2F

P2860

Understanding the epidemiology and progression of systemic lupus erythematosus

http://www.wikidata.org/entity/Q33621131

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Understanding the epidemiology and progression of systemic lupus erythematosus

@ast

Understanding the epidemiology and progression of systemic lupus erythematosus

@en

type

label

Understanding the epidemiology and progression of systemic lupus erythematosus

@ast

Understanding the epidemiology and progression of systemic lupus erythematosus

@en

prefLabel

Understanding the epidemiology and progression of systemic lupus erythematosus

@ast

Understanding the epidemiology and progression of systemic lupus erythematosus

@en

P1433

Q33621131-0F94701D-B67B-4F1D-B930-87C6BF45990C

P1476

Q33621131-C35B9150-B720-4A96-93B0-D2DE33167F05

P2093

Q33621131-0723D701-3F10-433E-B9B6-1BF179F8EAD0

Q33621131-36F823A2-5798-46B5-8847-1CB213AD3C3C

Q33621131-6569451B-4DE6-4768-B9E6-5BB5D4D6BB7D

Q33621131-BD58D0C1-8081-4138-9B31-8F2724A9F71C

Q33621131-E9524236-54BF-46F8-8BDA-9AFAA18A0653

P2860

Q33621131-03B4CC92-994E-42A7-B9D4-2D14CCF0F254

Q33621131-055FBDB4-DE65-472C-B58B-1B6C7FA11DD4

Q33621131-06961B56-5B1B-4A8C-BF17-55D4194EC681

Q33621131-08545506-497C-41EE-A542-5117D81EDC77

Q33621131-08C3CF83-67E9-4ED5-95D6-593AADD1FE6B

Q33621131-0ABB9896-C631-4020-BAE5-CFDB08BE81F6

Q33621131-0BD5BAEA-4B1E-4B13-B591-3F550E1EBFCC

Q33621131-0BD6CA90-FBB7-47D4-847A-DCAC00EDA612

Q33621131-0F35117F-D1E7-47BF-BF31-E8EDE7DF0F99

Q33621131-14BE52D1-E6B3-4E88-87B8-4A129026EBDA

P304

Q33621131-14CDA62F-C4B6-4029-B4BC-F8E0DC6AD65E

P31

Q33621131-450DB5C1-B4DD-4C65-A76B-668C43CDF1F1

P356

Q33621131-52FE00C7-ED2D-4E77-BC44-6D5B0D7CD6B5

P433

Q33621131-C3642E69-8AE8-44FF-8FF2-B7CC5CB9B567

P478

Q33621131-173DA76B-205F-4770-A50F-76E2A86BF95F

P577

Q33621131-23F1F2AF-0EBC-4264-A051-AA30903C1012

P5875

Q33621131-9074349F-BA5D-40C2-9C80-AF26047D8021

P698

Q33621131-F1A3C167-E8DD-47D3-B616-7CF00C9F2E21

P921

Q33621131-6FDA3DE5-7B23-4055-AD16-8E4AE6465EC5

P932

Q33621131-205B8D65-1466-4FAC-B542-DEDD4D529B44

P356

J.SEMARTHRIT.2008.10.007

P1433

Seminars in Arthritis and Rheumatism

P1476

Understanding the epidemiology and progression of systemic lupus erythematosus

@en

P2093

Glinda S Cooper

http://www.w3.org/2001/XMLSchema#string

Graciela S Alarcón

http://www.w3.org/2001/XMLSchema#string

Guillermo J Pons-Estel

http://www.w3.org/2001/XMLSchema#string

Lacie Scofield

http://www.w3.org/2001/XMLSchema#string

Leslie Reinlib

http://www.w3.org/2001/XMLSchema#string

P2860

Risk for rheumatic disease in relation to ethnicity and admixture.

The 1982 revised criteria for the classification of systemic lupus erythematosus

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data.

Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus.

A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population.

Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States.

Epidemiology treatment and outcome of childhood systemic lupus erythematosus in Egypt.

Lupus erythematosus in the 1980s: a survey of 570 patients.

Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death.

P304

257-268

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.SEMARTHRIT.2008.10.007

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23770423

http://www.w3.org/2001/XMLSchema#string

P698

19136143

http://www.w3.org/2001/XMLSchema#string

P921

P932

2813992

http://www.w3.org/2001/XMLSchema#string